Prescription drug · ANDA
JAYTHARI Oral Suspension (Deflazacort) NDC 70710-2131
Deflazacort 22.75 mg/mL · Suspension · Oral · Zydus Pharmaceuticals (USA) Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-2131-3 | 7071021310370710213103 | 1 BOTTLE in 1 CARTON (70710-2131-3) / 13 mL in 1 BOTTLEMarketed from Nov 20, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- JAYTHARI Oral Suspension
- Generic name (nonproprietary)
- deflazacort
- Active ingredients
- Deflazacort — 22.75 mg/mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Zydus Pharmaceuticals (USA) Inc.NDC labeler code 70710
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 220042
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 70710-2131_2ae3f985-ae3a-4d9a-98e3-d5d3d50c0490SPL ID 2ae3f985-ae3a-4d9a-98e3-d5d3d50c0490
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470710213103followed by a unit qualifier and the quantityPackage 70710-2131-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70710-2131
- What is NDC 70710-2131?
- 70710-2131 is the product NDC for JAYTHARI Oral Suspension (deflazacort), Deflazacort 22.75 mg/mL suspension, listed with the FDA by Zydus Pharmaceuticals (USA) Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- JAYTHARI Oral Suspension (Deflazacort).
- What is the active ingredient?
- Deflazacort.
- Who is the labeler?
- Zydus Pharmaceuticals (USA) Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for JAYTHARI Oral Suspension?
- 1 other product NDC are listed under this name. See all JAYTHARI Oral Suspension NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other JAYTHARI Oral Suspension products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| JAYTHARI Oral Suspensiondeflazacort | Deflazacort 22.75 mg/mL | SuspensionOral | Doppel Farmaceutici S.r.l. | 81806-213 | 81806-0213-13 |
Other NDCs under ANDA 220042
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Deflazacort Oral Suspensiondeflazacort | Deflazacort 22.75 mg/mL | SuspensionOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2007 |
| Deflazacort Oral Suspensiondeflazacort | Deflazacort 22.75 mg/mL | SuspensionOral | Doppel Farmaceutici S.r.l. | 81806-200 |
| JAYTHARI Oral Suspensiondeflazacort | Deflazacort 22.75 mg/mL | SuspensionOral | Doppel Farmaceutici S.r.l. | 81806-213 |